ProCE Banner Activity

Experts Highlight the Most Important Advances in HR+/HER2- Breast Cancer

Slideset

Download these expert-curated slides covering the evidence underlying the most important, clinically relevant recent advances in the management of patients with early and advanced HR+/HER2- breast cancer with a look ahead to expected new evidence that may change practice in the coming year.

Released: April 25, 2025

Expiration: October 24, 2025

Share

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by educational grants from Lilly and Stemline Therapeutics, Inc.

Lilly

Stemline Therapeutics, Inc.